Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator (AFR®)

Anja Lehner; Ingram Schulze-Neick; Nikolaus A Haas

doi:10.1017/S1047951118000720

Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator (AFR®)

Cardiol Young. 2018 Aug;28(8):1062-1066. doi: 10.1017/S1047951118000720. Epub 2018 Jul 4.

Authors

Anja Lehner¹, Ingram Schulze-Neick¹, Nikolaus A Haas¹

Affiliation

¹ Department for Pediatric Cardiology and Intensive Care,Ludwig Maximilians University (LMU),Klinikum der Universität München (KUM),Munich,Germany.

PMID: 29972113
DOI: 10.1017/S1047951118000720

Abstract

This report describes the first clinical experience with the new Occlutech Atrial Flow Regulator (AFR®) device for implementation of a late Fontan fenestration. The AFR® device secured a defined diameter of the fenestration without spontaneous re-occlusion of this extra-anatomic perforation. This ensured a permanent clinical improvement of our failing Fontan patient.

Keywords: CHD; Fontan circulation; new devices (in general); paediatric intervention; pulmonary hypertension; transseptal puncture.

Publication types

Case Reports

MeSH terms

Adult
Cardiac Catheterization / instrumentation*
Fontan Procedure / adverse effects*
Heart Defects, Congenital / surgery*
Humans
Hypertension, Pulmonary / complications*
Magnetic Resonance Imaging
Male
Prosthesis Design
Recurrence